CDK19
protein-codingcyclin dependent kinase 19, the group of Cyclin dependent kinases|Mediator complex
Gene summary
This gene encodes a protein that is one of the components of the Mediator co-activator complex. The Mediator complex is a multi-protein complex required for transcriptional activation by DNA binding transcription factors of genes transcribed by RNA polymerase II. The protein encoded by this gene is similar to cyclin-dependent kinase 8 which can also be a component of the Mediator complex. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
- CDK11
- CDC2L6
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~206.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030059
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0030059
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0030059
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CDK19 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015076.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 11 | 11 | ||||
| missense | 4 | 6 | 74 | 2 | 86 | |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 3 | 3 | ||||
| splice donor/acceptor (+/-2bp) | 6 | 6 | ||||
| Total | 4 | 6 | 86 | 13 | 0 | 109 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055891.1 | 13 | MANE Select | |
| Ensembl | ENSP00000357907.3 | 13 | MANE Select | |
| RefSeq | NP_001287889.1 | 12 | Standard | |
| RefSeq | NP_001287892.1 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Developmental Biology
- Transcriptional regulation of white adipocyte differentiation
Biological Process
- protein phosphorylation
- positive regulation of apoptotic process
- positive regulation of inflammatory response
- regulation of cell cycle
- cellular response to lipopolysaccharide
Molecular Function
- cyclin-dependent protein serine/threonine kinase activity
- ATP binding
- enzyme binding
Cellular Component
- nucleus
- cytosol
- mediator complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000368911
- Coding exons
- 13
- Length
- 205981
- Individuals with no LoFs
- 125660
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 3
- Defined
- 125663
- p
- 0.0000119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.56 | 114 | 283 | 0.403 | 0.0000145 | 3311 |
| Missense (PolyPhen) | 20 | 100.68 | 0.19864 | 1213 | ||
| Synonymous | 0.871 | 93 | 104 | 0.891 | 0.00000572 | 925 |
| Loss of Function | 4.82 | 1 | 29.0 | 0.0345 | 0.00000143 | 337 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000036 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.0850
Intolerance Scores
- LoFtool
- 0.0675
- RVIS EVS
- -0.23
- RVIS percentile EVS
- 36.86
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |